Trials / Completed
CompletedNCT00273429
Cosopt Versus Xalatan
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Pharmaceutical Research Network · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To compare the 24-hour efficacy and safety, measured every three hours, of the dorzolamide/timolol fixed combination given twice daily versus latanoprost and placebo each given once daily.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | timolol maleate 0.5% | |
| DRUG | dorzolamide/timolol maleate fixed combination | |
| DRUG | latanoprost 0.005% | |
| DRUG | placebo |
Timeline
- Start date
- 2005-04-01
- Completion
- 2005-12-01
- First posted
- 2006-01-09
- Last updated
- 2007-01-09
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00273429. Inclusion in this directory is not an endorsement.